Prof. Dr. Kin Lam Ken Yung ,The Education University ,Hong Kong
Dr. Yung Kin Lam Ken is a distinguished neuroscientist with over 25 years of experience in biology and innovative neuromedicine. Currently, he serves as the Associate Vice President (Research) and Chair Professor of Biology and Neuroscience at The Education University of Hong Kong. His pioneering work in anatomical neuropharmacology and neuroanatomy has yielded over 200 publications with an H-index of 39. A visionary researcher, Dr. Yung has secured funding exceeding HK$101 million and led impactful studies in Parkinson’s disease and Alzheimer’s therapies, breast cancer treatments, and environmental neuroscience.
Professional Profile
Suitable for Best Researcher Award
Prof. Ken Kin Lam Yung exemplifies the qualities of a world-class researcher, with a track record of high-impact publications, editorial leadership, and groundbreaking interdisciplinary research. His work addresses critical issues in neuroscience, environmental sustainability, and public health, underscoring his significant contributions to science and society. These attributes make him an outstanding contender for a Best Researcher Award.
🎓Education
- Doctor of Philosophy (1992–1995) – Anatomical Neuropharmacology, University of Oxford
- Master of Philosophy (1989–1992) – Neuroanatomy and Physiology, The University of Hong Kong
- Bachelor of Science (1st Honors, 1985–1989) – Applied Biology, Hong Kong Baptist College
Dr. Yung’s academic foundation spans neuropharmacology, neuroanatomy, and applied biology, contributing to his multidisciplinary expertise.
🏢Professional Experience
- Associate Vice President (Research) – The Education University of Hong Kong (2023–Present)
- Chair Professor of Biology & Neuroscience – The Education University of Hong Kong (2021–2023)
- Professor – Department of Biology, Hong Kong Baptist University (2005–2023)
- Assistant/Associate Professor – Department of Biology, Hong Kong Baptist University (1996–2005
Dr. Yung has significantly advanced neuromedicine, fostering collaborative research and academic excellence.
🏆Awards and Recognition
Multiple grants and awards, including:
- UGC-RGC Joint Funding Scheme (2024) – Research on Parkinson’s Disease (HK$1.2M)
- ITC-PRP Grant (2024) – Breast Cancer Preclinical Studies (HK$2M)
- Ma Pak Leung Endowed Professorship (2021) – Innovative Neuromedicine
Dr. Yung’s excellence is celebrated with prestigious accolades in research and innovation.
Expertise in :
- Anatomical neuropharmacology
- Neuroanatomy & physiology
- Advanced microscopy
- Pharmacological modeling
- Preclinical therapeutics
Dr. Yung combines technical proficiency with innovative approaches in biomedical research.
 
 Publication Top Notes
“Associations between fine particulate matter and colorectal cancer: A systematic review and meta-analysis”
- Authors: Fu, P.; Li, R.; Sze, S.C.W.; Yung, K.K.L.
- Journal: Reviews on Environmental Health, 2024, 39(3), pp. 447–457.
- Citations: 2
“Isoalantolactone exerts anti-melanoma effects via inhibiting PI3K/AKT/mTOR and STAT3 signaling in cell and mouse models”
- Authors: Li, J.-K.; Jiang, X.-L.; Zhang, Z.; Zhu, P.-L.; Yung, K.-K.-L.
- Journal: Phytotherapy Research, 2024, 38(6), pp. 2800–2817.
- Citations: 2
“Pollution characteristics and health risk assessment of PM2.5-bound polycyclic aromatic hydrocarbons (PAHs), nitro-PAHs, and halogenated-PAHs in Shanxi, China”
- Authors: Li, Z.; Hao, Q.; Yue, J.; Yung, K.K.L.; Li, R.
- Journal: Air Quality, Atmosphere and Health, 2024, 17(4), pp. 723–735.
- Citations: 1
“Regulation of PM2.5 on mitochondrial damage in H9c2 cells through miR-421/SIRT3 pathway and protective effect of miR-421 inhibitor and resveratrol”
- Authors: Chen, S.; Chen, W.; Li, Z.; Yung, K.K.L.; Li, R.
- Journal: Journal of Environmental Sciences (China), 2024, 138, pp. 288–300.
- Citations: 2
“Polystyrene microplastics induce size-dependent multi-organ damage in mice: Insights into gut microbiota and fecal metabolites”
- Authors: Zhang, Z.; Chen, W.; Chan, H.; Lin, K.; Yung, K.K.-L.
- Journal: Journal of Hazardous Materials, 2024, 461, Article ID: 132503.
- Citations: 25
“The volume regulated anion channel VRAC regulates NLRP3 inflammasome by modulating itaconate efflux and mitochondria function”
- Authors: Wu, X.; Yi, X.; Zhao, B.; Liu, S.; Zhou, P.
- Journal: Pharmacological Research, 2023, 198, Article ID: 107016.
- Citations: 4
“Caveolin-1 is critical for hepatic iron storage capacity in the development of nonalcoholic fatty liver disease”
- Authors: Deng, G.-H.; Wu, C.-F.; Li, Y.-J.; Lv, Z.-P.; Gao, L.
- Journal: Military Medical Research, 2023, 10(1), Article ID: 53.
- Citations: 6
“Exocarpium Citri Grandis alleviates the aggravation of NAFLD by mitigating lipid accumulation and iron metabolism disorders”
- Authors: Deng, G.; Liu, C.; Zhao, J.; Lam Yung, K.K.; Gao, L.
- Journal: Journal of Ethnopharmacology, 2023, 313, Article ID: 116559.
- Citations: 9
“A traditional prescription comprising Astragali Radix and Schisandra chinensis Fructus induces apoptosis and protective autophagy in hepatocellular carcinoma cells”
- Authors: Zhu, P.-L.; Li, J.-K.; Jiang, X.-L.; Chen, W.-Q.; Yung, K.-K.-L.
- Journal: Journal of Ethnopharmacology, 2023, 312, Article ID: 116548.
- Citations: 4